Trial intelligence / Profile preview

Cooled radiofrequency vs intra-articular steroid/local anesthetic injection for chronic hip pain

2018-000269-36Phase 4Active

Sponsor: JORGE ORDUÃ‘A VALLS
Start: Apr 2018
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries: 1

Overview

Phase 4, randomised trial of triamcinolone acetonide and ropivacaine in hip osteoarthritis and chronic hip pain (2 arms), sponsored by JORGE ORDUÃ‘A VALLS. Primary endpoint: Primary: Pain improvement on VAS. Started Apr 2018; status: active.

Drugs

triamcinolone acetonideropivacaine

Conditions

hip osteoarthritischronic hip pain

Beyond the preview

Go deeper on 2018-000269-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-000269-36.